KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) FCF Payout Ratio (2016 - 2025)

Abbott Laboratories (ABT) has disclosed FCF Payout Ratio for 17 consecutive years, with 0.39 as the latest value for Q4 2025.

  • Quarterly FCF Payout Ratio fell 12.05% to 0.39 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.56 through Dec 2025, down 7.85% year-over-year, with the annual reading at 0.56 for FY2025, 7.85% down from the prior year.
  • FCF Payout Ratio hit 0.39 in Q4 2025 for Abbott Laboratories, down from 0.45 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 1.53 in Q1 2024 to a low of 0.33 in Q4 2021.
  • Historically, FCF Payout Ratio has averaged 0.62 across 5 years, with a median of 0.46 in 2021.
  • Biggest five-year swings in FCF Payout Ratio: crashed 80.13% in 2021 and later skyrocketed 213.66% in 2023.
  • Year by year, FCF Payout Ratio stood at 0.33 in 2021, then surged by 47.43% to 0.48 in 2022, then dropped by 18.9% to 0.39 in 2023, then increased by 14.66% to 0.45 in 2024, then fell by 12.05% to 0.39 in 2025.
  • Business Quant data shows FCF Payout Ratio for ABT at 0.39 in Q4 2025, 0.45 in Q3 2025, and 0.67 in Q2 2025.